ATE271386T1 - Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält - Google Patents

Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält

Info

Publication number
ATE271386T1
ATE271386T1 AT97936149T AT97936149T ATE271386T1 AT E271386 T1 ATE271386 T1 AT E271386T1 AT 97936149 T AT97936149 T AT 97936149T AT 97936149 T AT97936149 T AT 97936149T AT E271386 T1 ATE271386 T1 AT E271386T1
Authority
AT
Austria
Prior art keywords
estrogen
progesten
product containing
single stage
combination product
Prior art date
Application number
AT97936149T
Other languages
English (en)
Inventor
Michael Jay Gast
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24757773&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE271386(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE271386T1 publication Critical patent/ATE271386T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97936149T 1996-07-26 1997-07-23 Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält ATE271386T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68679096A 1996-07-26 1996-07-26
PCT/US1997/012795 WO1998004269A1 (en) 1996-07-26 1997-07-23 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen

Publications (1)

Publication Number Publication Date
ATE271386T1 true ATE271386T1 (de) 2004-08-15

Family

ID=24757773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97936149T ATE271386T1 (de) 1996-07-26 1997-07-23 Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält

Country Status (16)

Country Link
EP (1) EP0956024B1 (de)
JP (1) JP2000515890A (de)
KR (1) KR100518102B1 (de)
CN (1) CN1186024C (de)
AT (1) ATE271386T1 (de)
AU (1) AU726091B2 (de)
BR (1) BR9710566A (de)
CA (1) CA2261689A1 (de)
DE (1) DE69729956T2 (de)
ES (1) ES2223081T3 (de)
HK (1) HK1022843A1 (de)
HU (1) HUP9904344A3 (de)
IL (1) IL127797A (de)
NZ (1) NZ333750A (de)
PT (1) PT956024E (de)
WO (1) WO1998004269A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2305267A3 (de) * 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Kombination von Ethinylestradiol und Drospirenon zur Verwendung als Verhütungsmittel
DK1598069T3 (da) * 1999-08-31 2009-07-06 Bayer Schering Pharma Ag Farmaceutisk præparat af ethinylestradiol og drospirenon til anvendelse som præventionsmiddel
CA2382426C (en) * 1999-08-31 2006-02-28 Schering Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
PL201878B1 (pl) * 2000-01-18 2009-05-29 Bayer Schering Pharma Ag Kompozycja farmaceutyczna w doustnej postaci dawkowania. zawierająca estrogen i drospirenon, zastosowanie kompozycji i preparat farmaceutyczny
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
CA2431521E (en) * 2000-12-14 2013-04-16 Ortho-Mcneil Pharmaceutical, Inc. Steroid hormone products and methods for preparing them
EP1216713A1 (de) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Zusammensetzungen von Estrogen-Zyklodextrin Komplexe
PT1635843E (pt) * 2003-06-25 2009-04-07 Bayer Schering Pharma Ag Terapia de substituição hormonal e de depressão compreendendo dienogest
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
AU2011226911B2 (en) * 2004-04-30 2014-06-19 Bayer Intellectual Property Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
MXPA06014579A (es) * 2004-07-07 2007-03-01 Wyeth Corp Regimenes de progestina ciclicos y equipos.
KR20070087141A (ko) * 2005-02-15 2007-08-27 바이엘 쉐링 파마 악티엔게젤샤프트 경구용 고형 피임약
EP1690529A1 (de) * 2005-02-15 2006-08-16 Schering AG Feste perorale Arzneiform zur Kontrazeption, die Dienogest und Ethinylestradiol enthält
EP1690543A1 (de) * 2005-02-15 2006-08-16 Schering AG Pharmazeutisches Präparat zur Kontrazeption
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
DE102008040908A1 (de) 2008-07-31 2010-02-11 Deere & Company, Moline Kühleranordnung für ein Fahrzeugkühlsystem
PL2324832T5 (pl) * 2009-11-09 2017-10-31 Biogena Naturprodukte Gmbh & Co Kg Suplement diety przy przyjmowaniu hormonalnych środków antykoncepcyjnych

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
DE69729956T2 (de) 2004-12-16
WO1998004269A1 (en) 1998-02-05
NZ333750A (en) 2000-09-29
CN1186024C (zh) 2005-01-26
KR100518102B1 (ko) 2005-10-04
PT956024E (pt) 2004-10-29
DE69729956D1 (de) 2004-08-26
AU726091B2 (en) 2000-11-02
IL127797A (en) 2004-08-31
JP2000515890A (ja) 2000-11-28
HUP9904344A2 (hu) 2000-05-28
EP0956024A1 (de) 1999-11-17
ES2223081T3 (es) 2005-02-16
HUP9904344A3 (en) 2001-03-28
EP0956024B1 (de) 2004-07-21
CN1226168A (zh) 1999-08-18
CA2261689A1 (en) 1998-02-05
BR9710566A (pt) 1999-08-17
IL127797A0 (en) 1999-10-28
KR20000029515A (ko) 2000-05-25
AU3888797A (en) 1998-02-20
HK1022843A1 (en) 2000-08-25

Similar Documents

Publication Publication Date Title
ATE271386T1 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
AU645637B2 (en) Contraceptive regimen
AU7537987A (en) Combination dosage form for pre-menopausal women
DK0491415T3 (da) Orale svangerskabsforebyggende midler med lavt østrogen
WO1998004246A3 (en) Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
DK0917466T3 (da) Oralt antikonceptionsmiddel
ATE249222T1 (de) Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0956024

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked